Articles by Natalie Grover

Natalie Grover

Latest from this author

FDA Seeks More Data On Sarepta Muscle Disorder Drug, Shares Slump

Sarepta Therapeutics Inc said the U.S. Food and Drug Administration had asked for additional data on its lead drug, delaying its marketing application by about six months.
    MOST Read
    1. Cucumbers Recalled in 15 States After Salmonella Outbreak Sickens Over 20
    2. Instagram Is Paying Creators Up to £16K to Recruit New Users from TikTok, YouTube and Beyond
    3. Congress Backs Plan to Air-Drop Flies Into Mexico to Stop Flesh-Eating Pest From Crossing the Border
    4. Farm Shop Milk Recalled Over Killer E. Coli Threat
    5. US Grocery Chain Orders Recall of Baby Food Pouches Due to Concerns of Lead Contamination
    News